182 related articles for article (PubMed ID: 14679070)
1. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
[TBL] [Abstract][Full Text] [Related]
2. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
[TBL] [Abstract][Full Text] [Related]
3. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling.
Myers MA; Davies JM; Tong JC; Whisstock J; Scealy M; Mackay IR; Rowley MJ
J Immunol; 2000 Oct; 165(7):3830-8. PubMed ID: 11034389
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
[TBL] [Abstract][Full Text] [Related]
6. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
7. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
8. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
[TBL] [Abstract][Full Text] [Related]
9. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
[TBL] [Abstract][Full Text] [Related]
10. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
11. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
[TBL] [Abstract][Full Text] [Related]
12. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes.
Hampe CS; Kockum I; Landin-Olsson M; Törn C; Ortqvist E; Persson B; Rolandsson O; Palmer J; Lernmark A
Diabetes Care; 2002 Aug; 25(8):1481-2. PubMed ID: 12145258
[No Abstract] [Full Text] [Related]
13. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
14. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
Fenalti G; Hampe CS; O'connor K; Banga JP; Mackay IR; Rowley MJ; El-Kabbani O
Mol Immunol; 2007 Feb; 44(6):1178-89. PubMed ID: 16930708
[TBL] [Abstract][Full Text] [Related]
16. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
Richter W; Shi Y; Baekkeskov S
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
[TBL] [Abstract][Full Text] [Related]
18. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
[TBL] [Abstract][Full Text] [Related]
19. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
20. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
